SOLV

Solventum (SOLV), a medical services company, demonstrates a strong track record of beating earnings estimates, with an average surprise of 21.57% over the last two quarters. The company's positive Earnings ESP of +2.81% combined with its Zacks Rank #3 suggests another earnings beat is likely in the near term.

Solventum (SOLV), a healthcare company spun off from 3M, is highlighted as a stock to watch with a #3 (Hold) Zacks Rank and a VGM Score of B. The company features attractive valuation metrics with a forward P/E ratio of 11.9 and has seen upward earnings estimate revisions, with an average earnings surprise of +13.2%.

The article explains how to identify medical stocks poised for earnings surprises using the Zacks Earnings ESP (Expected Surprise Prediction) tool. It highlights that combining a positive ESP with a Zacks Rank #3 or better has historically produced 70% positive surprises and 28.3% average annual returns. Two medical stocks are featured as examples: Solventum (SOLV) with a +2.81% ESP and ANI Pharmaceuticals (ANIP) with a +6.45% ESP, both expected to report earnings in early November 2026.